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Abstract 
 
Background: Mahwang-tang (MT) is a traditional Korean medicine consisting of six medicinal herbs and is used to 
treat the influenza-like diseases. 
Materials and Methods: We performed the simultaneous analysis of nine bioactive components in an MT sample 
using a high-performance liquid chromatography–diode array detector (HPLC–DAD) analysis. In addition, the MT 
sample was investigated the inhibitory effects against lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 
Results: Recovery of the nine marker compounds was 98.24–102.05% and relative standard deviations of intra-day and 
inter-day precisions of this method were 0.05–1.92% and 0.02–1.64%, respectively. Amounts of the nine bioactive 
compounds in the MT samples were 0.24–24.86 mg/g. To determine the biological activity of MT, its effects on the 
inflammatory reaction in LPS-treated RAW 264.7 macrophages were tested. The results suggest that MT possesses 
anti-inflammatory activity via suppression of the nitric oxide/prostaglandin E2 pathway. 
Conclusion: The established analytical method by HPLC–DAD is expected to help the quality control of MT samples 
or related herbal prescriptions. Our data also suggest that MT may be a potential therapeutic candidate for various 
inflammatory diseases. 
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Introduction 
 
Traditional herbal formulations commonly combine two or more medicinal herbs. Therefore, they contain many 
components and exhibit various biological activities. One of these traditional Korean herbal formulas, Mahwang-tang 
(MT) was first recorded in Shanghan Lun by Zhang Zhongjing in the later years of the Han dynasty (AD 200). Since 
then, it has been recorded in Dongui Bogam by Heo Jun in Korea (AD 1613). The MT decoction is manufactured from 
six herbs, Ephedrae Herba, Cinnamomi Ramulus, Glycyrrhizae Radix et Rhizoma, Armeniacae Semen, Zingiberis 
Rhizoma Crudus, and Allii Radix, combined in the ratio 5:3.3:1:1.7:1.7:1.7 based on dry weight. It has been used for 
many years in Korea to treat influenza-like symptoms such as headache, high fever, cough, and arthralgia (Heo, 2004). 
MT has been reported to show antipyretic (Kubo and Nishimura, 2007), viral myocarditic (Shijie et al., 2010), anti-
asthma (Ma et al., 2014), and chronic hepatitis C (Kainuma et al., 2002a; Kainuma et al., 2002b) effects. Analytical 
methods to determine various components—ephedrine, amygdalin, cinnamic acid, cinnamaldehyde, liquiritin, and 
glycyrrhizin—in a decoction of MT or Kampo medicines containing Ephedrae Herba using a reversed-phase high-
performance liquid chromatography (RP–HPLC) coupled with a UV–Vis or diode array detector (DAD) method have 
been reported (Okamura et al., 1999a; Okamura et al., 1999b; He et al., 2012). However, these methods were only 
quantitative analyses of the main components in MT or Kampo medicines containing Ephedrae Herba. In addition, 
there is a limit to verifying the analytical method. 
Inflammation is the body’s protective response against injurious stimuli, including bacteria, damaged cells, or 
irritants (Ferrero-Miliani et al., 2007). Various types of immune cells are involved in regulation of the immune response. 
In particular, macrophages display anti-inflammatory action and reduce the immune reaction through the production of 
pro-inflammatory mediators, including nitric oxide (NO) and prostaglandin E2 (PGE2) (Fujiwara and Kobayashi, 2005; 
Mills, 2012). Macrophage stimulation with immune stimulants such as lipopolysaccharide (LPS) mediates 
inflammation by enhancing the production of pro-inflammatory mediators (MacMicking et al., 1997). In this study, we 
examined the inhibitory effect on the inflammation of MT using RAW 264.7 murine macrophages. The inhibition of 
NO and PGE2 production, and expression of inducible nitric oxide (iNOS) and cyclooxygenase-2 (COX-2) by MT was 
evaluated to determine its anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 
In this study, HPLC analysis for simultaneous quantification of the nine components, that is, ephedrine HCl (1), 
amygdalin (2), liquiritin apioside (3), liquiritin (4), coumarin (5), cinnamic acid (6), cinnamaldehyde (7), glycyrrhizin 
(8), and 6-gingerol (9) in the MT sample was conducted using HPLC–DAD. In addition, we also evaluated the anti-
inflammatory activity of the MT decoction using RAW 264.7 cell line. 
 
Materials and Methods 
Plant materials 
 
Six raw herbs (Table 1), Ephedrae Herba, Cinnamomi Ramulus, Glycyrrhizae Radix et Rhizoma, Armeniacae 
Semen, Zingiberis Rhizoma Crudus, and Allii Radix were provided from the Korean herbal market, Naemome Dah 
(Ulsan, Korea), in February 2012. The botanical origins of the six crude materials were confirmed by pharmacognosists, 
Professor Je-Hyun Lee, College of Oriental Medicine, Dongguk University (Gyeongju, Korea) and Young-Bae Seo, 
College of Oriental Medicine, Daejeon University (Daejeon, Korea) according to the guidelines on the visual and 
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organoleptic examination of herbal medicine (Moon, 2006; Yun, 2008; Kim, 2011). Specimens of raw materials (2012–
KE48–1 to KE48–4) have been stored at the K-herb Research Center, Korea Institute of Oriental Medicine (KIOM). 
 Table 1: Single dose composition of MT. 
Herbal medicine Scientific name Family Origin Amount (g) 
Ephedrae Herba Ephedra sinica Stapf Ephedraceae China 11.25 
Cinnamomi Ramulus Cinnamomum cassia Presl Lauraceae Vietnam 7.50 
Glycyrrhizae Radix et 
Rhizoma 
Glycyrrhiza uralensis Fischer Leguminosae China 2.25 
Armeniacae Semen 
Prunus armeniaca Linne var. ansu 
Maximowicz 
Rosaceae China 3.75 
Zingiberis Rhizoma Crudus Zingiber officinale Roscoe Zingiberaceae Ulsan, Korea 3.75 
Allii Radix Allium fistulosum Linne Liliaceae Hanam, Korea 3.75 
Total amount    32.25 
 
Chemicals and reagents 
 
For the reference standards, compound 1 (95.0%) was provided by the Ministry of Food and Drug Safety 
(Cheongju, Korea); compounds 2 and 5 (both 99.0%) from Merck KGaA (Darmstadt, Germany); compound 3 (98.0%) 
from Shanghai Sunny Biotech (Shanghai, China); and compounds 4 (99.6%), 6 (98.0%), 7 (98.0%), 8 (99.0%), and 9 
(99.0%) from Wako Chemicals (Osaka, Japan). The chemical structures of the nine biomarker components subjected to 
quantitative analysis are shown in Fig. 1. The methanol, acetonitrile, and water used in the study were all HPLC-grade 
products and obtained from J.T. Baker (Phillipsburg, NJ, USA). The 2,2,2-trifluoroethanoic acid (TFA) for HPLC 
(99.0%) was provided from Merck KGaA (Darmstadt, Germany). 
Figure 1: Chemical structure of the nine bioactive compounds in MT. 
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Preparation of standard solutions 
  
 Individual standard stock solutions of the nine reference standards were prepared at a concentration of 1000 
g/mL using methanol and stored at 4C until use. 
 
Preparation of the MT water extract and quality control sample 
 
 MT water extract was composed of six crude herbal medicines as listed in Table 1 and prepared in KIOM. 
The six raw materials, 1,744 g of Ephedrae Herba, 1,163 g of Cinnamomi Ramulus, 349 g of Glycyrrhizae Radix et 
Rhizoma, 581 g of Armeniacae Semen, 581 g of Zingiberis Rhizoma Crudus, and 581 g of Allii Radix were mixed and 
placed in a 10-times mass of distilled water (50 L), then boiled for 2 h at 100°C under a pressure of 0.98 bar using an 
electric extractor (COSMOS-660; Kyungseo Machine Co., Incheon, Korea). The extracted water solution was filtered 
via the a standard sieve (No. 270, 53 m, 203 ; Chung Gye Sang Gong Sa, Seoul, Korea); then the filtered samples 
were lyophilized using a freezing dryer, PVT100 (IlShinBioBase, Yangju, Korea) to obtain a plwdered MT sample. The 
amount of lyophilized MT powder obtained was 226.2 g (yield: 4.5%). For the quantitative analysis of the nine 
biomarker compounds using HPLC–DAD, 100.0 mg of the freeze-dried MT sample was dissolved in 20 mL of 70% 
methanol by sonication for 20 min; then, the prepared sample solution for analysis of compounds 1, 2, and 7 was 
diluted twofold and filtered via a 0.2 m membrane filter (PALL Life Sciences, Ann Arbor, MI, USA) prior to injection 
to the HPLC equipment. 
 
Chromatographic analysis of the MT sample 
 
 Chromatographic analysis was carried out on a Shimadzu Prominence LC-20A series HPLC system (Kyoto, 
Japan) equipped with a Model LC-20AT solvent delivery pump, SIL-20A autosampler, CTO-20A column oven, DGU-
20A3 degasser, SPD-M20A DAD, and Lab Solutions software (Version 5.54 SP3). Waters SunFire C18 reversed-phased 
column (4.6  250 mm; 5 m, Milford, MA, USA) was used for the separation of the nine bioactive components and 
retained at 40°C. The mobile phases consisted of 0.1% (v/v) TFA in distilled water (A) and acetonitrile (B) and the 
gradient system for chromatographic separation was as follows: 10–60% B for 0–30 min, 60–100% B for 30–40 min, 
100% B for 40–45 min, 100–10% B for 45–50 min, and 10% B for 50–60 min with a flow rate of 1.0 mL/min. 
Injection volume was 10 L. 
 
Calibration curves, limits of detection (LOD), and limits of quantification (LOQ) 
 
Calibration curves were draw up by plotting the peak areas (y) of each compound against their corresponding 
concentration (x, g/mL) using prepared standard solutions. Samples were measured in triplicate to obtain a regression 
equation including slope, intercept, and correlation coefficient. The LOD and LOQ values were calculated using the 
calibration curve of each reference standard as follows: LOD = 3.3  S and LOQ = 10  S, where  is the standard 
deviation of the blank response and S is the slope of the calibration curve. 
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Precision and accuracy 
 
To determine the precision of the established HPLC–DAD method, intra- and inter-day tests were carried out 
within one day and three consecutive days according to the International Conference on Harmonization (ICH) guideline 
(ICH, 2005). Intra-day and inter-day precisions were assessed using the relative standard deviation (RSD) value as an 
evaluation index and RSD (%) was calculated by the following equation: RSD (%) = 100  standard deviation 
(SD)/mean. Reproducibility of this method was evaluated by the RSD value of the amount and retention time of each 
reference standard. The recovery was performed to assess the accuracy of this analytical method using the standard 
addition method and the recovery of each compound was calculated using the following equation: recovery (%) = 100 
 (found amount – original amount)/spiked amount. 
 
Cell culture 
 
Mouse macrophages RAW 264.7 (American Type Culture Collection, Rockville, MD, USA) were maintained 
in Dulbecco’s modified Eagle’s medium (DMEM, Gibco Inc., Grand Island, NY, USA) containing 5.5% heat-
inactivated fetal bovine serum (Gibco Inc.), penicillin and streptomycin (100 U/mL and 100 g/mL, respectively, 
Thermo Fisher Scientific, Rockford, IL, USA) at 37°C. 
 
Cytotoxicity assay 
 
RAW 264.7 cells were exposed to MT extract for 24 h. The cytotoxic effect of MT against RAW 264.7 
macrophages was assessed using a Cell Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan). The cell viability was 
calculated using the following equation: 
 
 
Measurement of NO and PGE2 production 
 
Cell supernatants were collected from RAW 264.7 cells treated with LPS (1 g/mL) in the presence or 
absence of MT extract, and subjected for analysis of NO generation (Griess Reagent System; Promega Corp., Madison, 
WI, USA) and PGE2 production (ELISA kit; Cayman Chemical Co., Ann Arbor, MI, USA), according to the 
manufacturers’ instructions. 
 
Reverse transcription-polymerase chain reaction (RT-PCR) 
 
Total RNA was prepared using Trizol reagent (Invitrogen Life Sciences, Carlsbad, CA, USA). cDNA was 
generated by the reverse transcription and subjected to PCR reactions using rTaq DNA polymerase (ELPIS Biotech  
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Inc., Daejeon, Korea). The relative mRNA levels of iNOS and COX-2 were analyzed and adjusted by the -actin 
expression. The amplification primers listed in Table 2.  
Table 2: List of primer sequences. 
 
Primer Sequences Temperature 
iNOS Forward 5′- TCA CCT ACT TCC TGG ACA TTA -3′ 
Reverse 5′- ACT TCC AGT CAT TGT ACT CTG -3′ 
59°C 
COX-2 Forward 5′-GTA TCA GAA CCG CAT TGC CTC TGA-3′ 
Reverse 5′-CGG CTT CCA GTA TTG AGG AGA ACA GAT-3′ 
59°C 
β-actin Forward 5′-ACC GTG AAA AGA TGA CCC AG-3′ 
Reverse 5′-TAC GGA TGA CAA CGT CAC AC-3′ 
57C 
 
Statistical analysis 
All values are expressed as the mean ± S.E.M. from three independent assays. The significant differences 
were considered significant at P < 0.05. 
 
Results and Discussion 
Optimization of chromatographic conditions 
 
To establish the optimal HPLC–DAD method for simultaneous analysis of the target analytes in the MT 
sample, the nine compounds shown in Fig. 1 were selected as marker compounds. These compounds belong to different 
chemical classes. Therefore, gradient elution was examined for simultaneous analysis of these compounds, such as a 
variety of acidic mobile phases (namely, acetic acid, formic acid, and trifluoroacetic acid) and organic solvents (namely, 
methanol and acetonitrile). Furthermore, HPLC parameters were also tested as follows: different C18 columns, namely a 
Phenomenex Gemini C18, Waters SunFire C18, and Shiseido Capcell Pak UG120 C18 (all 4.6  250 mm, 5 m) and 
column temperatures (30, 35, and 40C) to improve chromatographic separation with good baseline, resolution, and 
peak tailing. Thus, the optimal chromatographic separation conditions determined were a Waters SunFire C18 column at 
a column temperature of 40°C. In addition, the mobile phase was determined as a gradient flow of 0.1% (v/v) TFA in 
distilled water–acetonitrile systems. UV wavelengths for quantitative analysis of each analyte in the MT sample were 
set at 206 nm for compounds 1 and 2, 254 nm for compound 8, 275 nm for compounds 3–6, 280 nm for compound 9, 
and 288 nm for compound 7. 
 
System suitability 
 
System suitability of the established HPLC–DAD analytical method was confirmed by the parameters, a 
capacity factor (k), selectivity factor (), resolution (Rs), theoretical plate number (N), and tailing factor (Tf). The 
values for these parameters are shown in Table 3. 
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Table 3: System suitability of the nine biomarker compounds. 
Linearity, LOD, and LOQ 
The linearity, which is expressed by the coefficient of determination (r2) values of the nine compounds in the 
established analytical method ranged between 0.9999 and 1.0000. The LOD and LOQ values of all the analytes were 
0.01–0.38 and 0.02–01.16 g/mL, respectively. These results suggest that the linearity and sensitivity are very good in 
the seven tested concentration ranges for this analytical method (Table 4). 
Table 4: Linear range, regression equation, r2, LOD, and LOQ for the nine bioactive compounds in the MT sample. 
ay: peak area (mAU) of compounds; x: concentration (g/mL) of compounds. bLOD = 3.3  S.  cLOQ = 10  S. 
 
Recovery and precision 
The recovery was examined to assess the accuracy of the established analytical method in the MT sample. 
Extraction recoveries of compounds 1–9 in this method were 98.24–102.05% and the RSD was within 1.50% (Table 5). 
Compound 
Capacity 
factor (k) 
Separation 
factor () 
Number of theoretical plates 
(N) 
Resolution 
(Rs) 
Tailing factor 
(Tf) 
1 2.36 1.14 9494 2.28 1.13 
2 2.69 1.54 9704 2.28 0.91 
3 4.14 1.54 24953 1.12 1.13 
4 4.28 1.52 24830 1.12 1.09 
5 6.51 1.52 22357 4.66 1.04 
6 7.42 1.14 31709 4.66 1.05 
7 8.42 1.03 39641 1.34 1.30 
8 8.68 1.21 38610 1.34 1.19 
Compound 
Linear range 
(g/mL) 
Regression equationa r2 
LODb 
(g/mL) 
LOQc 
(g/mL) 
1 7.81–125.00 y = 21151.31x + 8837.74 0.9999 0.16 0.50 
2 7.81–500.00 y = 9380.10x + 564.20 0.9999 0.37 1.12 
3 1.56–100.00 y = 16795.26x – 4999.15 1.0000 0.36 1.08 
4 1.56–100.00 y = 34977.41x – 5507.76 1.0000 0.17 0.52 
5 1.56–100.00 y = 61766.38x – 21853.95 0.9999 0.10 0.29 
6 0.78–50.00 y = 85141.39x – 16724.01 0.9999 0.07 0.21 
7 1.56–100.00 y = 128109.55x – 28516.41 1.0000 0.01 0.02 
8 1.56–100.00 y = 8700.95x – 1917.68 1.0000 0.38 1.16 
9 0.31–20.00 y = 5605.95x + 1851.10 0.9999 0.02 0.07 
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RSD values for reproducibility evaluation were in the range 0.09–2.40% for the amount of the nine bioactive 
compounds and 0.03–0.28% for retention times of all the analytes (Table 6). In addition, the RSD values for intra-day 
and inter-day precision assays of the established analytical method were 0.05–1.92% and 0.02–1.64%, respectively 
(Table 7). These results suggest that the proposed analytical method for the quantification analysis of the nine bioactive 
components in the MT sample is a suitable method. 
Table 5: Recovery of the nine compounds in MT. 
aRecovery (%) = 100  (Found amount – Original amount)/Spiked amount. 
 
Analyte 
Original amount 
(g/mL) 
Spiked amount (g/mL) Found amount (g/mL) Recoverya (%) 
RSD 
(%) 
1 38.17 
8.00 46.18 100.14 1.16 
20.00 57.86 98.67 0.45 
40.00 77.73 98.89 0.34 
2 54.36 
12.00 66.46 100.83 1.50 
30.00 84.92 101.88 0.29 
60.00 113.39 98.39 0.46 
3 23.88 
4.00 27.88 99.94 1.28 
10.00 33.87 99.89 0.98 
20.00 43.57 98.41 0.29 
4 11.62 
2.00 13.61 99.91 1.25 
5.00 16.61 99.92 0.78 
10.00 21.58 99.67 0.71 
5 24.22 
4.00 28.20 99.38 0.96 
10.00 34.24 100.20 0.50 
20.00 44.02 99.00 0.54 
6 8.86 
2.00 10.86 100.10 0.71 
5.00 13.84 99.53 0.24 
10.00 19.00 101.40 0.24 
7 34.09 
8.00 41.95 98.24 0.29 
15.00 49.40 102.05 0.36 
30.00 63.89 99.31 0.28 
8 36.32 
6.00 42.29 99.42 0.82 
15.00 51.10 98.50 0.50 
30.00 65.96 98.80 
0.24 
 
9 1.73 
1.00 2.73 100.34 1.00 
2.00 3.74 100.35 0.33 
4.00 5.76 100.82 0.81 
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Table 6: Reproducibility of retention times and amount for the nine bioactive components (n = 6). 
Analyte 
Retention time (min) Amount (g/mL) 
Mean  SD (10–1) RSD (%) Mean  SD RSD (%) 
1 9.11  0.06 0.07 38.17  0.04 0.09 
2 9.96  0.04 0.04 54.32  0.19 0.35 
3 13.91  0.23 0.16 24.04  0.50 2.08 
4 14.29  0.40 0.28 11.65  0.28 2.40 
5 20.31  0.23 0.12 24.23  0.15 0.61 
6 22.77  0.22 0.10 8.86  0.02 0.21 
7 25.44  0.09 0.03 34.07  0.09 0.26 
8 26.17  0.22 0.08 36.31  0.06 0.16 
9 31.14  0.23 0.07 1.73  0.01 0.83 
 
Table 7: Intra- and inter-day precision assays of the nine bioactive components in MT. 
Compound 
Spiked 
Conc. 
(g/mL) 
Intra-day (n = 5) Inter-day (n = 5) 
Observed 
Conc. 
(g/mL) 
Precision 
(%) 
Accuracy 
(%) 
Observed 
Conc. 
(g/mL) 
Precision 
(%) 
Accuracy 
(%) 
1 
8.00 8.09 0.62 101.08 8.07 0.71 100.84 
20.00 19.91 0.14 99.55 19.89 0.35 99.44 
40.00 40.03 0.05 100.07 40.04 0.08 100.11 
2 
12.00 11.96 0.90 99.68 11.99 0.94 99.93 
30.00 30.72 0.32 102.41 30.68 0.55 102.27 
60.00 59.65 0.07 99.41 59.66 0.14 99.44 
3 
4.00 4.01 0.47 100.20 4.04 0.94 101.06 
10.00 10.10 0.48 100.97 10.11 1.64 101.09 
20.00 19.95 0.13 99.75 19.94 0.40 99.68 
4 
2.00 2.00 1.14 100.02 2.00 0.88 100.01 
5.00 5.01 0.80 100.16 5.01 0.87 100.26 
10.00 10.00 0.17 99.96 9.99 0.21 99.93 
5 
4.00 3.98 0.54 99.59 3.96 0.80 98.98 
10.00 10.09 0.57 100.87 10.17 0.64 101.66 
20.00 19.96 0.13 99.80 19.93 0.13 99.66 
6 
2.00 2.00 0.47 100.17 2.01 0.46 100.41 
5.00 4.94 0.25 98.75 4.93 0.10 98.55 
10.00 10.03 0.05 100.31 10.03 0.02 100.35 
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7 
8.00 7.84 0.19 98.06 7.78 0.19 97.29 
15.00 15.33 0.36 102.18 15.30 0.10 102.00 
30.00 29.88 0.10 99.59 29.91 0.02 99.69 
8 
6.00 6.08 1.28 101.31 5.98 1.10 99.72 
15.00 15.07 1.92 100.44 15.16 1.52 101.04 
30.00 30.23 1.56 100.77 29.93 0.36 99.75 
9 
1.00 1.00 0.62 99.89 0.99 1.34 99.24 
2.00 1.99 0.70 99.71 2.01 0.79 100.37 
4.00 4.00 0.14 100.08 4.00 0.20 99.95 
HPLC analysis of the nine bioactive components in the MT sample 
 
The HPLC–DAD analytical method established here was successfully applied to analyze compounds 1–9 in 
the MT sample simultaneously. All target compounds were identified based on a comparison of the retention time and 
UV spectra of each reference standard. Thus, the compounds 1–9 were detected at 9.11, 9.96, 13.91, 14.29, 20.31, 
22.77, 25.44, 26.17, and 31.14 min, respectively (Fig. 2). Contents of the nine bioactive compounds in freeze-dried MT 
samples were in the range of 0.24–24.86 mg/g (Table 8). The results showed that the amount of most components 
determined is similar in different batches. In addition, the determined nine components could be considered as quality 
assessment markers for consistent research on MT quality. 
Table 8: Contents of the nine bioactive compounds in the MT sample. 
Analyte 
Content (mg/g)  SD (10–2) of lyophilized sample (n = 3) 
Sample 1 Sample 2 Sample 3 
1 15.47  1.03 15.60  3.31 15.32  1.45 
2 24.65  8.56 24.86  2.21 24.07  43.96 
3 5.22  0.01 5.26  0.54 5.14  6.47 
4 2.32  1.17 2.36  1.39 2.31  0.03 
5 4.97  0.32 5.03  0.64 4.93  1.97 
6 1.86  0.14 1.87  0.14 1.82  3.13 
7 13.80  5.05 13.87  7.71 13.80  9.28 
8 7.36  0.91 7.44  0.78 7.33  0.32 
9 0.25  0.37 0.24  0.45 0.25  0.45 
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Figure 2: HPLC chromatogram of standard solution (A) and MT test solution at 206 nm (I), 254 nm (II), and 275 nm 
(III). Ephedrine HCl (1), amygdalin (2), liquiritin apioside (3), liquiritin (4), coumarin (5), cinnamic acid (6), 
cinnamaldehyde (7), glycyrrhizin (8), and 6-gingerol (9). 
 
Cytotoxic effect of MT extract in RAW 264.7 cells 
 
To evaluate the cytotoxicity of MT against RAW 264.7 cells, cells were exposed to various concentrations of 
MT water extract (15.625, 31.25, 62.5, 125, 250, 500, or 1000 µg/mL) for 24 h. As shown in Fig. 3, MT had no 
cytotoxic effect up to 500 µg/mL while reducing the viability by 34.43% at 1000 µg/mL of the treatment. Nontoxic 
concentrations of MT extract were used for subsequent in vitro assays. 
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Figure 3: Cytotoxicity of MT in RAW 264.7 macrophages. Cells were exposed to various concentrations of MT extract 
(15.625, 31.25, 62.5, 125, 250, 500, or 1000 µg/mL) for 24 h. Cell viability (%) was assessed using a CCK-8 assay. The 
values are expressed as the mean ± S.E.M. of three independent experiments. MT: Mahwang-tang. 
 
Inhibitory effects of the MT extract on the levels of inflammatory mediators in LPS-stimulated RAW 264.7 
macrophages 
 
We examined whether MT has anti-inflammatory effects by measuring production of NO and PGE2. To 
induce in vitro inflammation, RAW 264.7 murine macrophages were stimulated with LPS (1 µg/mL). LPS stimulation 
significantly increased the level of NO (Fig. 4A). In contrast, MT treatment significantly reduced LPS-stimulated NO 
production at 250 and 500 µg/mL. In addition, LPS treatment significantly increased the amount of PGE2 whereas MT 
dramatically suppressed LPS-mediated PGE2 production in a dose-dependent manner (Fig. 4B). L-NG-monomethyl 
arginine (NMMA) and indomethacin (IND) were used as positive controls for NO and PGE2, respectively. In parallel, 
concurrent administration of LPS and MT extract suppressed the mRNA expression of iNOS and COX-2 in a dose-
dependent manner compared with LPS alone (Fig. 5). 
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Figure 4: Effect of MT on LPS-stimulated NO and PGE2 production in RAW 264.7 macrophages. The levels of NO 
(A) and PGE2 (B) were measured in culture medium from cells pretreated with MT extract (125, 250, or 500 g/mL) 
for 4 h and then stimulated with LPS (1 g/mL) for an additional 20 h. NMMA (100 M) and IND (2.5 ng/mL) were 
used as positive control drugs for (A) and (B), respectively. Each bar graph represents the mean of three independent 
experiments. ###P < 0.001 vs. vehicle control group; ***P < 0.001 or **P < 0.01 vs. LPS-treated cells. MT: Mahwang-
tang; NMMA: L-NG-monomethyl arginine; and IND: indomethacin. 
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Figure 5: Effect of MT on the mRNA expression of iNOS and COX-2 in LPS-stimulated RAW 264.7 macrophages. 
Cells were pretreated with MT extract (125, 250, or 500 g/mL) for 1 h and then stimulated with LPS (1 g/mL) for an 
additional 5 h. Total RNA was isolated from the cell pellets and subjected to RT-PCR for detecting iNOS and COX-2 
mRNA expression. Levels of iNOS and COX-2 were adjusted by -actin expression.  
 
Conclusion 
 
The established HPLC–DAD method for quantitative assessment of MT decoction was validated by the linearity, 
reproducibility, recovery, and precision validations. This method was anticipated to support the quality control of MT 
decoction or related herbal formulations. Furthermore, MT showed inhibitory effects on the production of inflammatory 
mediators NO and PGE2 in LPS-activated RAW 264.7 macrophages. Consistently, MT suppressed LPS-stimulated 
expression of iNOS and COX-2 at the mRNA level. Our findings indicate the potent activity of MT as an anti-
inflammatory drug candidate. Additional work will be necessary to confirm further its activity by analyzing the 
regulatory mechanisms using in vitro or in vivo models.  
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